Emerging roles of fibronectin in thrombosis

Thrombosis Research

Volumn 125, Issue 4, 2010, Pages 287-291

  Maurer, Lisa M ^a   Tomasini Johansson, Bianca R ^a   Mosher, Deane F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPTIFIBATIDE; FIBRONECTIN;

ATHEROSCLEROSIS; DISEASE ASSOCIATION; DRUG MECHANISM; HEART INFARCTION; HEMOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; THROMBOCYTE; THROMBOGENESIS; THROMBOSIS;

ANIMALS; BLOOD PROTEINS; CRICETINAE; EXTRACELLULAR MATRIX; FIBRINOGEN; FIBRONECTINS; MORPHOGENESIS; THROMBOSIS; WOUND HEALING;

EID: 77949566812     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.12.017     Document Type: Review

References (65)

1. Pankov R., and Yamada K.M. Fibronectin at a glance. J Cell Sci 115 Pt 20 (2002 Oct 15) 3861-3863
2. O'Leary J.M., Hamilton J.M., Deane C.M., Valeyev N.V., Sandell L.J., and Downing A.K. Solution structure and dynamics of a prototypical chordin-like cysteine-rich repeat (von Willebrand Factor type C module) from collagen IIA. J Biol Chem 279 51 (2004 Dec 17) 53857-53866
3. Schmidt B., and Hogg P.J. Search for allosteric disulfide bonds in NMR structures. BMC Struct Biol 7 (2007) 49
4. White E.S., Baralle F.E., and Muro A.F. New insights into form and function of fibronectin splice variants. J Pathol 216 1 (2008 Sep) 1-14
5. Moretti F.A., Chauhan A.K., Iaconcig A., Porro F., Baralle F.E., and Muro A.F. A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived. J Biol Chem 282 38 (2007 Sep 21) 28057-28062
6. Tomasini-Johansson B.R., Annis D.S., and Mosher D.F. The N-terminal 70-kDa fragment of fibronectin binds to cell surface fibronectin assembly sites in the absence of intact fibronectin. Matrix Biol 25 5 (2006 Jul) 282-293
7. Geiger B., Bershadsky A., Pankov R., and Yamada K.M. Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol, Cell Biol 2 11 (2001 Nov) 793-805
8. Zerlauth G., and Wolf G. Plasma fibronectin as a marker for cancer and other diseases. Am J Med 77 4 (1984 Oct) 685-689
9. Hynes R.O. Fibronectins (1990), Springer-Verlag, New York
10. Thompson C., Blumenstock F.A., Saba T.M., Feustel P.J., Kaplan J.E., Fortune J.B., et al. Plasma fibronectin synthesis in normal and injured humans as determined by stable isotope incorporation. J Clin Invest 84 4 (1989 Oct) 1226-1235
11. Schwarzbauer J.E., Spencer C.S., and Wilson C.L. Selective secretion of alternatively spliced fibronectin variants. J Cell Biol 109 6 Pt 2 (1989 Dec) 3445-3453
12. Chauhan A.K., Kisucka J., Cozzi M.R., Walsh M.T., Moretti F.A., Battiston M., et al. Prothrombotic effects of fibronectin isoforms containing the EDA domain. Arterioscler Thromb Vasc Biol 28 2 (2008 Feb) 296-301
13. Castellanos M., Leira R., Serena J., Blanco M., Pedraza S., Castillo J., et al. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke 35 7 (2004 Jul) 1671-1676
14. Peters J.H., Maunder R.J., Woolf A.D., Cochrane C.G., and Ginsberg M.H. Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury. J Lab Clin Med 113 5 (1989 May) 586-597
15. Tan M.H., Sun Z., Opitz S.L., Schmidt T.E., Peters J.H., and George E.L. Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood 104 1 (2004 Jul 1) 11-18
16. Cho J., and Mosher D.F. Role of fibronectin assembly in platelet thrombus formation. J Thromb Haemost 4 7 (2006 Jul) 1461-1469
17. Paul J.I., Schwarzbauer J.E., Tamkun J.W., and Hynes R.O. Cell-type-specific fibronectin subunits generated by alternative splicing. J Biol Chem 261 26 (1986 Sep 15) 12258-12265
18. Ni H., Papalia J.M., Degen J.L., and Wagner D.D. Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain. Blood 102 10 (2003 Nov 15) 3609-3614
19. Shirakami A., Shigekiyo T., Hirai Y., Takeichi T., Kawauchi S., Saito S., et al. Plasma fibronectin deficiency in eight members of one family. Lancet 1 8479 (1986 Mar 1) 473-474
20. Sakai T., Johnson K.J., Murozono M., Sakai K., Magnuson M.A., Wieloch T., et al. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat Med 7 3 (2001 Mar) 324-330
21. Acharya S.S., and Dimichele D.M. Rare inherited disorders of fibrinogen. Haemophilia 14 6 (2008 Nov) 1151-1158
22. Iismaa S.E., Mearns B.M., Lorand L., and Graham R.M. Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev 89 3 (2009 Jul) 991-1023
23. Olorundare O.E., Peyruchaud O., Albrecht R.M., and Mosher D.F. Assembly of a fibronectin matrix by adherent platelets stimulated by lysophosphatidic acid and other agonists. Blood 98 1 (2001 Jul 1) 117-124
24. Mosesson M.W. Fibrinogen and fibrin structure and functions. J Thromb Haemost 3 8 (2005 Aug) 1894-1904
25. Zhai Z., Wu J., Xu X., Ding K., Ni R., Hu W., et al. Fibrinogen controls human platelet fibronectin internalization and cell-surface retention. J Thromb Haemost 5 8 (2007 Aug) 1740-1746
26. Ni H., Denis C.V., Subbarao S., Degen J.L., Sato T.N., Hynes R.O., et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 106 3 (2000 Aug) 385-392
27. Reheman A., Yang H., Zhu G., Jin W., He F., Spring C.M., et al. Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor. Blood 113 8 (2009 Feb 19) 1809-1817
28. Castelletti F., Donadelli R., Banterla F., Hildebrandt F., Zipfel P.F., Bresin E., et al. Mutations in FN1 cause glomerulopathy with fibronectin deposits. Proc Natl Acad Sci U S A 105 7 (2008 Feb 19) 2538-2543
29. Cho J., and Mosher D.F. Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi. Blood 107 9 (2006 May 1) 3555-3563
30. Tomasini-Johansson B.R., Kaufman N.R., Ensenberger M.G., Ozeri V., Hanski E., and Mosher D.F. A 49-residue peptide from adhesin F1 of Streptococcus pyogenes inhibits fibronectin matrix assembly. J Biol Chem 276 26 (2001 Jun 29) 23430-23439
31. Orem C., Durmus I., Kilinc K., Baykan M., Gokce M., Orem A., et al. Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness. Coron Artery Dis 14 3 (2003 May) 219-224
32. Ekmekci H., Ekmekci O.B., Sonmez H., Ozturk Z., Domanic N., and Kokoglu E. Evaluation of fibronectin, vitronectin, and leptin levels in coronary artery disease: impacts on thrombosis and thrombolysis. Clin Appl Thromb Hemost 11 1 (2005 Jan) 63-70
33. Song K.S., Kim H.K., Shim W., and Jee S.H. Plasma fibronectin levels in ischemic heart disease. Atherosclerosis 154 2 (2001 Feb 1) 449-453
34. Ulutin T., Sonmez H., Ucisik N., Suer S., Bayram C., Kokoglu E., et al. The molecular markers of hemostatic activation on coronary artery disease. Thromb Res 88 3 (1997 Nov 1) 329-332
35. Zhang Y., Zhou X., Krepinsky J.C., Wang C., Segbo J., and Zheng F. Association study between fibronectin and coronary heart disease. Clin Chem Lab Med 44 1 (2006) 37-42
36. Vavalle J.P., Wu S.S., Hughey R., Madamanchi N.R., and Stouffer G.A. Plasma fibronectin levels and coronary artery disease. J Thromb Haemost 5 4 (2007 Apr) 864-866
37. Pecheniuk N.M., Elias D.J., Deguchi H., Averell P.M., and Griffin J.H. Elevated plasma fibronectin levels associated with venous thromboembolism. Thromb Haemost 100 2 (2008 Aug) 224-228
38. Tomasini-Johansson B.R., and Mosher D.F. Plasma fibronectin concentration in inbred mouse strains. Thromb Res 102 6 (2009 Dec) 1278-1280
39. Matuskova J., Chauhan A.K., Cambien B., Astrof S., Dole V.S., Piffath C.L., et al. Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles. Arterioscler Thromb Vasc Biol 26 6 (2006 Jun) 1391-1396
40. Ni H., Yuen P.S., Papalia J.M., Trevithick J.E., Sakai T., Fassler R., et al. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci U S A 100 5 (2003 Mar 4) 2415-2419
41. Westrick R.J., Winn M.E., and Eitzman D.T. Murine models of vascular thrombosis (Eitzman series). Arterioscler Thromb Vasc Biol 27 10 (2007 Oct) 2079-2093
42. Guan J.L., Trevithick J.E., and Hynes R.O. Retroviral expression of alternatively spliced forms of rat fibronectin. J Cell Biol 110 3 (1990 Mar) 833-847
43. McDonald J.A. Fibronectin in the Lung. In: Mosher D.F. (Ed). Fibronectin (1989), Academic Press, Inc, San Diego 363-393
44. Davi G., and Patrono C. Platelet activation and atherothrombosis. N Engl J Med 357 24 (2007 Dec 13) 2482-2494
45. Labat-Robert J., Marques M.A., N'Doye S., Alperovitch A., Moulias R., Allard M., et al. Plasma fibronectin in French centenarians. Arch Gerontol Geriatr 31 2 (2000 Oct 1) 95-105
46. Furie B., and Furie B.C. Mechanisms of thrombus formation. N Engl J Med 359 9 (2008 Aug 28) 938-949
47. Cho J., Degen J.L., Coller B.S., and Mosher D.F. Fibrin but not adsorbed fibrinogen supports fibronectin assembly by spread platelets. Effects of the interaction of alphaIIb beta3 with the C terminus of the fibrinogen gamma-chain. J Biol Chem 280 42 (2005 Oct 21) 35490-35498
48. Corti A., Curnis F., Arap W., and Pasqualini R. The neovasculature homing motif NGR: more than meets the eye. Blood 112 7 (2008 Oct 1) 2628-2635
49. Moon D.G., Kaplan J.E., and Mazurkewicz J.E. The inhibitory effect of plasma fibronectin on collagen-induced platelet aggregation. Blood 67 2 (1986 Feb) 450-457
50. Santoro S.A. Inhibition of platelet aggregation by fibronectin. Biochem Biophys Res Commun 116 1 (1983 Oct 14) 135-140
51. Dixit V.M., Haverstick D.M., O'Rourke K., Hennessy S.W., Broekelmann T.J., McDonald J.A., et al. Inhibition of platelet aggregation by a monoclonal antibody against human fibronectin. Proc Natl Acad Sci U S A 82 11 (1985 Jun) 3844-3848
52. Thurlow P.J., Kenneally D.A., and Connellan J.M. The role of fibronectin in platelet aggregation. Br J Haematol 75 4 (1990 Aug) 549-556
53. Cho J., and Mosher D.F. Impact of fibronectin assembly on platelet thrombus formation in response to type I collagen and von Willebrand factor. Blood 108 7 (2006 Oct 1) 2229-2236
54. Cho J., and Mosher D.F. Characterization of fibronectin assembly by platelets adherent to adsorbed laminin-111. J Thromb Haemost 4 5 (2006 May) 943-951
55. Bae E., Sakai T., and Mosher D.F. Assembly of exogenous fibronectin by fibronectin-null cells is dependent on the adhesive substrate. J Biol Chem 279 34 (2004 Aug 20) 35749-35759
56. Ingham K.C., Brew S.A., and Isaacs B.S. Interaction of fibronectin and its gelatin-binding domains with fluorescent-labeled chains of type I collagen. J Biol Chem 263 10 (1988 Apr 5) 4624-4628
57. Ensenberger M.G., Annis D.S., and Mosher D.F. Actions of the functional upstream domain of protein F1 of Streptococcus pyogenes on the conformation of fibronectin. Biophys Chem 112 2-3 (2004 Dec 20) 201-207
58. McKeown-Longo P.J., and Mosher D.F. Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts. J Cell Biol 100 (1985) 364-374
59. Schor S.L., Ellis I., Banyard J., and Schor A.M. Motogenic activity of IGD-containing synthetic peptides. J Cell Sci 112 Pt 22 (1999 Nov) 3879-3888
60. Millard C.J., Ellis I.R., Pickford A.R., Schor A.M., Schor S.L., and Campbell I.D. The role of the fibronectin IGD motif in stimulating fibroblast migration. J Biol Chem 282 49 (2007 Dec 7) 35530-35535
61. Intengan H.D., and Schiffrin E.L. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38 3 Pt 2 (2001 Sep) 581-587
62. Chiang H.Y., Korshunov V.A., Serour A., Shi F., and Sottile J. Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol 29 7 (2009 Jul) 1074-1079
63. Magnusson M.K., and Mosher D.F. Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol 18 9 (1998 Sep) 1363-1370
64. Frontini M.J., O'Neil C., Sawyez C., Chan B.M., Huff M.W., and Pickering J.G. Lipid incorporation inhibits Src-dependent assembly of fibronectin and type I collagen by vascular smooth muscle cells. Circ Res 104 7 (2009 Apr 10) 832-841
65. Dobaczewski M., Gonzalez-Quesada C., and Frangogiannis N.G. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol (2009 Jul 23)